![Stuart Arbuckle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stuart Arbuckle
Direktor/Vorstandsmitglied bei
RHYTHM PHARMACEUTICALS, INC.
Vermögen: 33 Mio $ am 31.05.2026
Profil
Stuart A. Arbuckle ist ein unabhängiger Direktor bei Rhythm Pharmaceuticals, Inc. und ein unabhängiger Direktor bei ImmunoGen, Inc. sowie ein Chief Operating Officer & Executive Vice President bei Vertex Pharmaceuticals, Inc. Er ist Mitglied des Verwaltungsrats von Rhythm Pharmaceuticals, Inc. und ImmunoGen, Inc. sowie der Biotechnology Innovation Organization und der Cancer Support Community. Herr Arbuckle war zuvor als Vice President & GM-Oncology Business Unit bei Amgen, Inc. und als Principal bei GlaxoSmithKline Plc. beschäftigt. Außerdem war er Vorstandsmitglied bei Cerulean Pharma, Inc. und Wellness Community. Seinen Bachelor-Abschluss machte er an der University of Leeds.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.03.2026 | 68’515 ( 0.03% ) | 31 Mio $ | 31.05.2026 | |
| 24.06.2026 | 11’712 ( 0.02% ) | 1 Mio $ | 31.05.2026 | |
| 10.06.2026 | 2’537 ( 0.01% ) | 887 874 $ | 31.05.2026 |
Aktive Positionen von Stuart Arbuckle
| Unternehmen | Position | Beginn |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 24.07.2019 |
| ALNYLAM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 05.01.2026 |
| PRAXIS PRECISION MEDICINES, INC. | Direktor/Vorstandsmitglied | 08.01.2026 |
Cancer Support Community
 Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides cancer support services | Direktor/Vorstandsmitglied | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Stuart Arbuckle
| Unternehmen | Position | Ende |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Geschäftsführer | 01.07.2025 |
| IMMUNOGEN, INC. | Direktor/Vorstandsmitglied | 12.02.2024 |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Direktor/Vorstandsmitglied | 01.07.2017 |
| AMGEN INC. | Corporate Officer/Principal | 01.08.2012 |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Stuart Arbuckle
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellness Community
 Wellness Community Miscellaneous Commercial ServicesCommercial Services Provides professional programs of emotional support, education and hope for people impacted by cancer | Commercial Services |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides cancer support services | Commercial Services |
Wählen Sie MarketScreener 
